Skip to content

The Joint Corp. JYNT Issuance of vested restricted stock units

Issuance of vested restricted stock units at other companies

ARD
Ardent Health PartnersARDT
-$1.01M+4.4%

Other financials

Income statement

See full
Revenue$14.8M+13.3%
Gross profit$12.1M+19.7%
Operating income$873.7K+229%
Net income$1.3M+34.2%
EPS (diluted)$0.09+50.0%

Balance sheet

See full
Cash & equivalents$21.4M-6.4%
Total debt$2.0M-9.3%
Total equity$15.5M-22.3%
Total assets$57.9M-25.0%

Cash flow

See full
Operating cash flow-$1.5M+60.1%
CapEx$234.6K-29.2%
Free cash flow-$1.7M+57.6%

Valuation

See full
Market cap$127.87M-28.0%
Enterprise value$108.49M-27.1%
P/E39.5×
P/S2.3×-0.2×

Profitability

See full
Gross margin80.6%-6.0pp
Operating margin1.1%+0.7pp
Net margin5.7%+3.7pp
FCF margin7.2%-0.4pp

Returns & leverage

See full
Return on equity18.3%+11.6pp
Debt / equity0.1×0.0×
Current ratio1.6×+0.1×

Where this comes from

Reported directly by The Joint Corp. in its filing.

Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures.

The official record: The Joint Corp.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Joint Corp.'s issuance of vested restricted stock units.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Joint Corp.'s issuance of vested restricted stock units?
The Joint Corp. (JYNT) reported issuance of vested restricted stock units of $0 in Q1 2026.
What does issuance of vested restricted stock units mean?
This metric measures the total dollar value of restricted stock units (RSUs) vested and issued to employees and directors during the reporting period. It serves as a key indicator of equity-based compensation strategy and potential shareholder dilution. Investors monitor this to assess the alignment between management incentives and long-term shareholder value.